Health X Platform Limited Releases Investor Presentation for November 2026
Health X Platform Limited released an investor presentation on Nov 14, 2026. The company reported a 58% YoY revenue growth and an 18% QoQ growth. Gross margin widened by 80 bps to 8.3% in Sep-26 quarter. Operating leverage improved with Opex falling as a % of revenue. Net working capital days stood at 23.
The investor presentation provides detailed operational and financial insights, including growth metrics and strategic direction, which are important for investors to assess the company's future prospects.
The announcement highlights strong revenue growth, expanding gross margins, and improving operating leverage, indicating positive business performance and strategic execution.
Health X Platform Limited (formerly Sastasundar Ventures Limited) has released an investor presentation on November 14, 2026. The presentation details the company's performance, strategic initiatives, and future outlook.
Key highlights include sustained top-line momentum with a 58% year-on-year revenue growth and an 18% quarter-on-quarter growth. The company has also seen an expansion in its gross margin, widening by 80 basis points year-on-year to 8.3% in the quarter ended September 2026, driven by better sourcing, an increased private-label mix, and channel optimization. Operating leverage is improving, with Opex falling as a percentage of revenue, leading to expanding EBIT margins.
The presentation also covers the company's asset-light, low-leverage model, which results in minimal depreciation and finance costs, constituting only 0.8% of revenue. Working capital efficiency is highlighted, with net working capital days at 23 days, achieved through disciplined management of receivables, inventory, and payables.
The company's 'Health X Ecosystem' is built on value delivered with efficiency, impact driven by empathy, innovation powered by technology, and trust built on authenticity. The RetailAir platform, a mobile-first SaaS solution for pharmacies, is also detailed, offering features like mobile-first billing, inventory management with AI insights, and GST filing readiness.
Growth track records for SastaSundar and Retailer Shakti are presented, showcasing significant CAGR figures. Despite a past partnership with Flipkart, the company has regained full control and is now 100% owned, positioning it for future scaling. The company emphasizes its deep rural inclusion, with a significant portion of its business driven by Tier 2 and Tier 3 markets, validating its mission to democratize healthcare access.
Financial data for the quarter ended September 2026 shows revenue from operations at ₹489.1 crore, with a gross margin of 8.3%. The consolidated profit and loss statement for Q2 FY27 indicates a loss for the period, but the company's strategic focus on profitable growth is evident through its operational efficiencies and market reach. The company is building for the future, focusing on B2B consolidation, distributor private-label brands, data-driven omnichannel experiences, AI-led behavior shifts, and the rise of preventive care.
What to do with a filing like this
Health X Platform Limited filed this with the NSE as a statutory disclosure, categorised under investor presentation. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Health X Platform Limited. Read the original for the full detail.